Biosynthesis and secretion of alpha-1-proteinase inhibitor (a1PI) has been demonstrated in primary cultures of human mononuclear phagocytes, making it possible to study regulation of a1PI in normal (PiMM) and homozygous-deficient (PiZZ) individuals.
Introduction Alpha-l-proteinase inhibitor (a1PI)1 is thought to play an important role in elastic tissue injury and repair because it rapidly inactivates neutrophil elastase (reviewed in reference 1) . It is a 1. Abbreviations used in this paper: a1PI, alpha-l-proteinase inhibitor;
Con A, concanavalin A; DME, Dulbecco's modified Eagle's medium; IL-1 and IL-2, interleukins 1 and 2; PWM, pokeweed mitogen; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; TPCK, N-tosyl-L-phenyl-alanine chloromethyl ketone. 52,000-55,000-mol-wt single-chain glycoprotein encoded by a 10.2-kilobase (kb) gene (2) on human chromosome 14 (3, 4) . Several polymorphic variants of this inhibitor (PiZZ and PiSZ) have been associated with moderate to severe reduction in plasma concentration of the inhibitor, chronic liver disease, and pulmonary emphysema.
Liver is the predominant site of synthesis (5, 6) , but human monocytes and macrophages also synthesize and secrete a1PI (7) . Furthermore, the cellular defect in homozygous PiZZ aPI deficiency, a selective decrease in rate of secretion of aPI, is expressed in human monocytes from PiZZ individuals (8) . Thus, blood monocytes and tissue macrophages in primary cell culture make it possible to study the expression and regulation of aPI in normal and deficient individuals.
Although plasma concentrations of a1PI are known to increase during acute inflammation, pregnancy, and oral contraceptive administration (9) , relatively little information about the regulation of aPI is available. In primary cultures of human blood monocytes, bronchoalveolar macrophages, and breast milk macrophages we previously observed a decrease in aPI messenger RNA (mRNA) content and a corresponding decrease in synthesis and secretion of aPI during the first 10 d in culture (7) . This decrease in expression of aP1 during maturation in culture was not caused by a change in cell viability or total metabolic activity, as total protein synthesis and synthesis of other specific secreted proteins increased during that interval. These observations suggested that ajPI was regulated by a factor elaborated in vitro or by loss of an in vivo regulating factor. Expression of DR antigen by human monocytes also decreases during the first week in culture but the decrease can be prevented by the addition ofa lymphocyte product, interferon-gamma, to the cell culture fluid (10) . In the following study, another lymphokine was shown to increase the expression of a1PI in mononuclear phagocytes, and, as a result, to accentuate the defect in secretion of a1PI in severely deficient individuals.
Behring Corp., San Diego, CA, concanavalin A (Con A) from Miles Laboratories, Naperville, IL; Ficoll from Pharmacia AB, Uppsala, Sweden; sodium diatrizoate (Hypaque sodium 50% wt/vol) from Winthrop Laboratories; immobilized N-tosyl-L-phenyl-alanine chloromethyl ketone (TPCK) trypsin from Worthington Biochemicals, Freehold, NJ; pokeweed mitogen (PWM) from Burroughs Wellcome, Research Triangle Park, NC; cesium chloride from Bethesda Research Laboratories, Gaithersburg, MD; guanidine isothiocyanate from Fluka AG, Buchs, Switzerland; and sodium N-laurylsarcosinate from ICN Pharmaceuticals, Plainville, NY. Rabbit anti-human aPI was purchased from Dako Corp., Santa Barbara, CA; goat anti-human a1PI, goat anti-human lysozyme, goat anti-human factor B, and goat anti-human C3 were obtained from Atlantic Antibodies, Scarborough, ME. Recombinant-generated human interferons were obtained from Roche Institute of Molecular Biology, Nutley, NJ (alpha), Cetus Corp., Emeryville, CA (beta), and Genentech, San Francisco, CA (gamma). The specific activity of interferon-gamma was 1.9 X 107 IU antiviral activity/mg protein. Purified human monocyte interleukin 1 (IL-1) was a gift from C. A. Dinarello (Boston, MA). Supernatants from alloantigen-stimulated T4' lymphocyte clones were gifts from Dr. R. Geha (Boston, MA).
Separation and culture of monocytes and macrophages. Confluent monolayers of human peripheral blood monocytes were established by adherence ofdextran-purified leukocytes on siliconized glass as previously described (1 1). Bronchoalveolar macrophages were obtained from sterile saline bronchial lavage, and breast milk macrophages were from milk expressed during the first 4 d of lactation. After centrifugation and washing, cells were allowed to adhere to siliconized glass coverslips ( 12, 13) .
Lymphokines. Peripheral blood mononuclear cells (2 X 10/ml) were isolated by Ficoll-Hypaque density gradient centrifugation (14) , depleted of monocytes by one adherence step, and then incubated for 2-6 d in RPMI 1640 containing 2% heat-inactivated fetal calf serum, 0.05 mM 2-mercaptoethanol, 5 mM Hepes, 100 U/ml penicillin, 100 Ag/ml streptomycin, 2 mM L-glutamine with 2 gg/ml Con A or 10 gg/ml PWM.
After centrifugation, supernatants were separated from cells, filtered, and stored at -70°C. Some aliquots were dialyzed against DME lacking methionine so that they could be included in cell culture fluid during biosynthetic labeling. Control culture supernatants were prepared by culturing peripheral blood mononuclear cells in the same medium but supplementing with Con A or PWM only after supernatants were separated from cells. Supernatants were also obtained from Con A-stimulated T lymphocytes and from alloreactive T4+ lymphocyte clones (15) . T lymphocytes were collected from peripheral blood specimens by Ficoll-Hypaque centrifugation, enrichment by rosetting with sheep erythrocytes, passage of E+ cells through nylon wool columns, and cultivation ofcells not adhering to siliconized glass surfaces. In specified experiments crude lymphokine preparations were incubated at 56°C and 70°C for 60 min or to 100°C for 5 min, adsorbed by immobilized TPCK-treated trypsin in 0.05 M Tris HCl (pH 8.0)10.05 M NaCl for 60 min at 37°C or adsorbed by 5-500 ng mouse monoclonal anti-human interferon-gamma. The effect of these lymphokine preparations on a1PI expression by mononuclear phagocytes was then compared to that ofthe usual preparations.
Biosynthetic labeling. Confluent monolayers were rinsed and incubated at 37°C for 3 h in the presence of methionine-free medium containing [35Slmethionine (500 ACi/ml). Methods for solubilization ofcells and clarification of cell lysates after labeling have been described (7). Total protein synthesis was estimated by trichloroacetic acid (TCA) precipitation of aliquots of cell lysates and culture fluid ( 16) .
Immunoprecipitation and SDS-polyacrylamide gel electrophoresis (PAGE). For immunoprecipitation, aliquots of cell lysate or medium were incubated overnight at 4°C in 1% Triton X-100/1.0% SDS/0.5% deoxycholic acid, with excess antibody. Immune complexes were precipitated with excess formalin-fixed staphylococci-bearing protein A, washed, released by boiling in sample buffer, and applied to 9.0% SDS-PAGE under reducing conditions as described by Laemmli (17) . 14C-methylated molecular size markers (200,000, 92,500, 68,000, 46,000, and 30,000 mol wt) were included on all gels. After electrophoresis, gels were stained in Coomassie Brilliant Blue, destained, impregnated with 2,5-diphenyloxazole (EN3HANCE, New England Nuclear), and dried for fluorography on XAR x-ray film (Eastman Kodak Co., Rochester, NY). Complexing of aPI with proteases was examined by treatment of extracellular media with protease in 0.05 M Tris HCl (pH 8.0)/0.05 NaCl at 250C for 10 min. Reactions were terminated with 100-fold excess phenylmethylsulfonyl fluoride. Proteases included bovine alpha-chymotrypsin and porcine pancreatic elastase.
Detection of RNA by RNA blot analysis. Total cellular RNA was isolated from adherent monolayers of monocytes and macrophages by guanidine isothiocyanate extraction and ethanol precipitation (18). RNA was quantitated by absorbance at 260 nm and solubilized for agaroseformaldehyde gel electrophoresis and transfer to nitrocellulose filters (19) . Filters were then hybridized with 32P-labeled a PI-specific complementary (c) DNA (20) , complement factor B-specific cDNA (21) , and complement C3-specific cDNA (22) . After hybridization, filters were washed extensively, dried, and exposed to x-ray film for autoradiography.
Results
Effect of crude lymphokine on aPI expression by monocytes and macrophages. Peripheral blood monocytes were maintained in culture for 10 d. At specified intervals, monolayers were incubated with supernatants of unstimulated and Con A-stimulated peripheral blood mononuclear cells and then biosynthetically labeled for 3 h (Fig. 1) . As shown in previous experiments (7), synthesis and secretion of a, PI decreased during these 10 d in culture, as total protein synthesis and synthesis ofother specific proteins, such as lysozyme, complement proteins C2 and factor B, increased (data not shown). Incubation with the crude lymphokine, however, led to an increase in expression of a1PI by days 4-6, but even more noticeably by days 7-9 in culture. In- Supernatants from Con A-stimulated mononuclear cells also increased expression of a1PI by alveolar and breast milk macrophages (Fig. 2, left) . The effect of the lymphokine on a1PI expression was specific, in that total protein synthesis and synthesis of another specific protein, complement component C3 (Fig. 2, right) , were not affected. tent corresponding to the increase in synthesis and secretion of a1PI (Fig. 3) . There was also an increase in factor B mRNA content but no change in C3 mRNA content in lymphokinetreated macrophages (data not shown).
Characteristics of the lymphokine stimulating aPI expression. The effect of supernatant from Con A-stimulated mononuclear cells on a1PI expression was dose-and time-dependent (Fig. 4) . Expression of a1PI increased with increasing relative lymphokine concentration to 270 (dilution 1:10), decreasing slightly at higher relative concentrations (Fig. 4, left) . At the optimal relative lymphokine concentration the increase in a1PI was 200-250% of control, as demonstrated by direct scintillation counting of radiolabeled bands excised from the gels of four separate experiments (Fig. 5) . At this relative lymphokine concentration, expression of a1PI was -55-60% of that present in the cell culture fluid of unstimulated monocytes during the first 24 h in culture. The effect of the lymphokine on synthesis and secretion of a1P1 reached its maximum between 24 and 48 h of incubation (Fig. 4, right) . There was no further change between 48 and 72 h of incubation in lymphokine. The increase in a1PI expression was not produced by a direct action of Con A or a product of unstimulated peripheral blood mononuclear cells on monocytes (Fig. 6 ).
Supernatants were also collected from peripheral blood mononuclear cells stimulated with Con A or PWM for varying intervals from 2 to 6 d. a1PI expression by monocytes increased after incubation in each of these supernatants but increased RELAT/VE CONCEN7RA TION Figure 5 . 24 -h incubation with recombinant-generated human interferon-alpha A, interferon-alpha D, interferon-beta, interferongamma, or interleukin 2 (IL-2) at concentrations at 1-1,000 U/ ml, or with purified human IL-l at concentrations of 0.5-12.5 U/ml (not shown). At these concentrations, interferon-alpha and interferon-gamma increased expression of complement C2 and factor B (24) . Depletion of interferon-gamma in supernatants of Con A-stimulated peripheral blood mononuclear cells by adsorption with anti-human interferon-gamma did not abrogate the effect on monocyte ajPI expression.
Effect of crude lymphokine on aPI expression in PiZZ monocytes. Synthesis of aPI by PiZZ monocytes also increased in the presence of lymphokine (Fig. 7) . Furthermore, the increase in the 52,000-mol wt intracellular form of a1PI in PiZZ monocytes treated with lymphokine is accentuated when compared with the change in the 55,000-mol wt native extracellular a1PI. The accentuation of intracellular a1PI accumulation in PiZZ monocytes by the lymphokine was selective, in that total TCAprecipitable protein and other specific proteins were not similarly affected. Factor B and C3 (Fig. 7 , center and right) were increased proportionally in intracellular lysates and extracellular media of lymphokine-treated PiZZ monocytes.
Discussion
The results of these experiments demonstrate that a product of mitogen-stimulated peripheral blood mononuclear cells increases the expression of a1PI in human monocytes and macrophages by a pretranslational mechanism. This factor also increases the expression of aPI by monocytes from homozygous PiZZ-deficient individuals, and in so doing, accentuates the defect in secretion of aPI in these individuals. The regulating factor has the characteristics of a polypeptide and is probably elaborated by T lymphocytes, but it is not an interferon or IL-2.
The expression of aPI by monocytes is also regulated by time in culture and by interaction with serine protease (7) . During the first 24 h in culture, synthesis and secretion of a,PI is maximal and aIPI appears in the cell culture fluid in native and proteasecomplexed forms. Synthesis and secretion of a1PI progressively decreases during the first week in culture, but the small amount of a1PI detectable in cell culture fluid by 7-10 d is almost entirely in native form. These data suggest that the serine protease(s) which interacts with ajPI early in culture is either passively adsorbed to the cell surface but progressively lost during culture or that de novo synthesis of serine protease(s) by monocytes decreases abruptly during the first 4 d in culture. In either case, the factor present in supernatants of mitogen-stimulated peripheral blood mononuclear cells independently regulates the expression of a1PI, since only the native 55,000-mol wt form increased in cell culture fluid of treated monocytes. It might be argued that serine protease expression was also increased by this lymphokine but not detected because a corresponding increase in release of oxygen radicals resulted in functional inactivation of a1PI. This possibility was excluded by demonstrating the formation of a complex after the addition of exogenous protease to the cell culture fluid of lymphokine-treated monocytes.
Changes in the expression of aPI in monocytes during culture are not simply a reflection of cellular differentiation. Although aPI is secreted in native form alone by the "late" monocyte and alveolar macrophage, it is also in complex form in the cell culture fluid ofbreast milk macrophages. Expression of aPI in macrophages of either type decreases over 7-10 d in culture while synthesis of total TCA-precipitable protein and other specific proteins remains unchanged. Finally, the ratio of a1PI in native to complexed form and the apparent size of complex forms vary between monocyte and breast milk macrophage, suggesting that there is independent regulation of serine protease and ajPI in different local microenvironments. The expression of several other mononuclear phagocyte secretory proteins is increased by lymphokines. Interferon-gamma mediates an increase in expression of complement proteins C2 and factor B in monocytes and macrophages (24) . Crude lymphokine supernatants increase synthesis and secretion of Cl inhibitor (25) , plasminogen activator urokinase (26), and procoagulant activity (27) by monocytes. The lymphokine responsible for enhanced monocyte procoagulant activity is also derived from a T lymphocyte of the helper/inducer subset (28) . A separate T lymphocyte cell-associated pathway may also increase monocyte procoagulant activity (28) (29) (30) . Further studies will be necessary to identify the source and identity ofthe mediator(s) responsible for the increase in expression of a1PI by monocytes and macrophages.
Most important, however, will be further studies ofregulation of mononuclear phagocyte aPI expression by lymphokine as a model for the effect of enhanced synthesis on a defect in posttranslational processing/secretion, i.e., homozygous PiZZ aPI deficiency. If the presence or severity of intracellular aPI accumulation is a factor involved in the development of chronic liver disease and/or pulmonary emphysema, differences in the elaboration of this lymphokine and similar mediators in the local environment of the target organs may contribute to the wide variability in disease manifestations among PiZZ individuals.
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